PGFC
TTPH

Peapack-Gladstone Financial Corp’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,000
Closed -$10K – 368
2019
Q2 		$10K Buy
+1,000
New +$18.4K ﹤0.01% 355

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Peapack-Gladstone Financial Corp's TTPH Position: Q3 2019 in Review

Peapack-Gladstone Financial Corp sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2019, closing a stake of 1,000 shares — an estimated $10K sold.

Peapack-Gladstone Financial Corp first reported a position in TTPH in Q2 2019 and held it in 1 quarter. The position peaked at $10K in Q2 2019. 26 funds tracked by Wall St. Rank hold TTPH as of Q3 2019.

  • Peapack-Gladstone Financial Corp reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Peapack-Gladstone Financial Corp sold 1,000 Tetraphase Pharmaceuticals, Inc. shares in Q3 2019, an estimated $10K.
  • Peapack-Gladstone Financial Corp first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2019 and held it in 1 quarter.
  • Peapack-Gladstone Financial Corp's Tetraphase Pharmaceuticals, Inc. position peaked at $10K in Q2 2019.
  • 26 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2019.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q3 2019, filed 13 Nov 2019.